Summary & Overview
CPT 4220F: No Summary Available
CPT code 4220F is listed in clinical coding resources without an accompanying descriptive summary in the provided input. As a CPT entry, it represents a standardized code intended for clinical documentation, quality reporting, or procedure classification used across payers and providers nationwide. Accurate identification of such codes matters because payers rely on CPT codes for claims adjudication, quality measurement, and health services research.
Key national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what 4220F signifies given the available information, guidance on where to find missing clinical detail, and the likely implications for billing workflows and claims processing when a code lacks a published summary. The publication highlights the need to reference authoritative CPT resources and payer-specific fee schedules or policy manuals for definitive interpretation.
This summary outlines the scope of content available: code identification, the absence of a narrative description in the input, and next steps for clinicians, coders, and policymakers to obtain definitive clinical and billing context from CPT publications and payer documentation.
Billing Code Overview
CPT code 4220F — No Summary found for this code. This code is recorded as a CPT performance or quality-related entry but a narrative description is not available in the source input. Service type: Data not available in the input. Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient otolaryngology or oral and maxillofacial surgery clinic with chronic or recurrent nasopharyngeal or oropharyngeal symptoms such as nasal obstruction, epistaxis, recurrent sinusitis, or suspected neoplasm. The clinician performs an endoscopic nasopharyngeal evaluation and documents tissue appearance; targeted biopsies are taken when mucosal irregularity, mass, or ulceration is identified. Local anesthesia and topical vasoconstrictors are used; the procedure is performed under endoscopic guidance with tissue specimens submitted for histopathology. Relevant workflow steps include pre-procedure consent and history, topical anesthesia and vasoconstriction, direct visualization with rigid or flexible endoscope, targeted biopsy sampling, specimen labeling and submission, brief hemostasis, and post-procedure instructions with pathology follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | When a distinct E/M visit is provided on the same day as the biopsy and must be reported separately |
59 | Distinct procedural service |